Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment
Daniel I. Brierley, Colin Davidson
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2012) Vol. 39, Iss. 2, pp. 263-272
Closed Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication
Peng Wang, Juan Carlos Álvarez-Pérez, Dan P. Felsenfeld, et al.
Nature Medicine (2015) Vol. 21, Iss. 4, pp. 383-388
Open Access | Times Cited: 349
Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada
Gerald Thomas, Philippe Lucas, N. Rielle Capler, et al.
Current Drug Abuse Reviews (2013) Vol. 6, Iss. 1, pp. 30-42
Closed Access | Times Cited: 295
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos, Flávia de Lima Osório, José Alexandre S. Crippa, et al.
Therapeutic Advances in Psychopharmacology (2016) Vol. 6, Iss. 3, pp. 193-213
Open Access | Times Cited: 274
Neuropharmacology of N,N-dimethyltryptamine
Theresa M. Carbonaro, Michael B. Gatch
Brain Research Bulletin (2016) Vol. 126, pp. 74-88
Open Access | Times Cited: 204
Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial
Raíssa Nóbrega de Almeida, Ana Cecília de Menezes Galvão, Flávia Santos da Silva, et al.
Frontiers in Psychology (2019) Vol. 10
Open Access | Times Cited: 145
Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B
Tania Tahtouh, Jonathan M. Elkins, P. Filippakopoulos, et al.
Journal of Medicinal Chemistry (2012) Vol. 55, Iss. 21, pp. 9312-9330
Closed Access | Times Cited: 178
Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness
Jonathan Hamill, Jaime E. C. Hallak, Serdar Dursun, et al.
Current Neuropharmacology (2018) Vol. 17, Iss. 2, pp. 108-128
Open Access | Times Cited: 144
Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells
Peng Wang, Esra Karaköse, Hongtao Liu, et al.
Cell Metabolism (2018) Vol. 29, Iss. 3, pp. 638-652.e5
Open Access | Times Cited: 135
Therapeutic Effects of Ritual Ayahuasca Use in the Treatment of Substance Dependence—Qualitative Results
Anja Loizaga-Velder, Rolf Verres
Journal of Psychoactive Drugs (2014) Vol. 46, Iss. 1, pp. 63-72
Closed Access | Times Cited: 131
GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration
Courtney Ackeifi, Peng Wang, Esra Karaköse, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 530
Open Access | Times Cited: 104
Acute Biphasic Effects of Ayahuasca
Eduardo Ekman Schenberg, João Felipe Morel Alexandre, Renato Filev, et al.
PLoS ONE (2015) Vol. 10, Iss. 9, pp. e0137202-e0137202
Open Access | Times Cited: 100
Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat
Aline Pic‐Taylor, Luciana Gueiros da Motta, Juliana Alves de Morais, et al.
Behavioural Processes (2015) Vol. 118, pp. 102-110
Closed Access | Times Cited: 91
Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact
Andreia Machado Brito-da-Costa, Diana Dias da Silva, Nelson G. M. Gomes, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 11, pp. 334-334
Open Access | Times Cited: 86
DYRK1A inhibitors for disease therapy: Current status and perspectives
Tong Liu, Yuxi Wang, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 114062-114062
Closed Access | Times Cited: 73
Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT
Steven A. Barker
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1749-1763
Open Access | Times Cited: 38
Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases
Mattias F. Lindberg, Emmanuel Deau, Jonas Arfwedson, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 6, pp. 4106-4130
Closed Access | Times Cited: 25
Exploring DMT: Endogenous Role and Therapeutic Potential
J. Schimmelpfennig, Kamila Jankowiak-Siuda
Neuropharmacology (2025), pp. 110314-110314
Open Access | Times Cited: 1
Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology
Rafael G. dos Santos
Journal of Psychoactive Drugs (2013) Vol. 45, Iss. 1, pp. 68-78
Closed Access | Times Cited: 84
Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice
A.J. Oliveira-Lima, Renato Antunes dos Santos, A.W. Hollais, et al.
Physiology & Behavior (2015) Vol. 142, pp. 28-36
Open Access | Times Cited: 83
Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans
Amanda Amorin Nunes, Rafael G. dos Santos, Flávia de Lima Osório, et al.
Journal of Psychoactive Drugs (2016) Vol. 48, Iss. 3, pp. 195-205
Open Access | Times Cited: 83
Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca
Paulo César Ribeiro Barbosa, Luís Fernando Tófoli, Michael P. Bogenschutz, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 78
Harmine is an inflammatory inhibitor through the suppression of NF-κB signaling
Xin Liu, Mingxia Li, Si Tan, et al.
Biochemical and Biophysical Research Communications (2017) Vol. 489, Iss. 3, pp. 332-338
Closed Access | Times Cited: 73
Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell Proliferation
Kunal Kumar, Peng Wang, Roberto Sánchez, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 17, pp. 7687-7699
Open Access | Times Cited: 68
Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers
Jerome Sarris, Daniel Perkins, Lachlan Cribb, et al.
Journal of Affective Disorders Reports (2021) Vol. 4, pp. 100098-100098
Open Access | Times Cited: 55
DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes
Kunal Kumar, Chalada Suebsuwong, Peng Wang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 6, pp. 2901-2922
Closed Access | Times Cited: 53
Page 1 - Next Page

Scroll to top